^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Adrenal Cortex Carcinoma
    Drug:carboplatin (Tubulin polymerization promoter) +
    etoposide IV (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Adrenocortical carcinoma: Systemic therapy for locoregional unresectable/metastatic adrenocortical carcinoma…preferred regimens…Carboplatin + etoposide